Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Q1 2025 Earnings Call Transcript May 13, 2025
Zevra Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.21.
Operator: Good afternoon and thank you for joining Zevra’s First Quarter 2025 Financial Results and Corporate Update Conference Call. Today’s call is being recorded, and will be available via the Investor Relations section of the company’s website later today. The host for today’s call is Nichol Ochsner,...
